Related Experiment Videos

NF-AT-luciferase reporter T cell lines as tools to screen immunosuppressive drugs

C T Baldari1, M M Di Somma, M B Majolini

  • 1IRIS-Biocine, Siena, Italy.

Insights

Researchers developed new Jurkat T cell lines that efficiently detect immunosuppressants like cyclosporin A. These reporter cell lines enable faster screening for novel immunosuppressive drug analogues for transplantation and autoimmune diseases.

Area of Science:

  • Immunology
  • Molecular Biology
  • Drug Discovery

Background:

  • Development of safer immunosuppressants is crucial for transplantation and autoimmune disease treatments.
  • Cyclosporin A and FK506 are key immunosuppressive drugs with potential for analogue development.
  • Existing screening methods can be time-consuming and labor-intensive.

Purpose of the Study:

  • To generate and characterize novel Jurkat T cell reporter lines for screening immunosuppressants.
  • To establish a sensitive and efficient assay for detecting T cell receptor-derived signals.
  • To facilitate the automated screening of cyclosporin A and FK506 analogues.

Main Methods:

  • Stable transfection of Jurkat T cells with a luciferase reporter construct under NF-AT control.
  • Characterization of reporter cell line response to T cell receptor stimulation.
  • Optimization of a simplified luciferase assay for high-throughput screening.

Main Results:

  • Generated Jurkat T cell lines exhibiting cyclosporin A-sensitive responses to T cell receptor signals.
  • Demonstrated high luciferase activity, enabling detection with fewer than 1000 cells.
  • Developed a simplified assay reducing time and manipulation for screening.

Conclusions:

  • The novel Jurkat T cell reporter lines provide a sensitive and efficient model for drug screening.
  • These cell lines are valuable tools for identifying novel immunosuppressive drug analogues.
  • The simplified assay format supports automated screening for cyclosporin A and FK506 analogues.

Related Concept Videos